03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Telebrix 30 Meglumine° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Intermedic |
Distributor | Intermedic |
Laboratory | Guerbet |
Responsible Party | Guerbet |
Origin | France |
Manufacturer | Guerbet France |
Origin | France |
ATC | V08AA05 |
Telebrix 30 Meglumine° :
Telebrix 30 Meglumine° :
Telebrix 30 Meglumine° :
Telebrix 30 Meglumine° :
Telebrix 30 Meglumine° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Telebrix 30 Meglumine° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Not known |
Agitation | Not known |
Anaphylactic reactions | Not known |
Anaphylactic shock | Not known |
Anaphylactoid reactions | Not known |
Angina pectoris | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anuria | Not known |
Arrhythmia | Not known |
Blood creatinine increased | Not known |
Bronchospasm | Not known |
Cardiac arrest | Not known |
Cephalea | Not known |
Circulatory collapse | Not known |
Coma | Not known |
Confusional state | Not known |
Convulsion | Not known |
Cough | Not known |
Diarrhoea (Diarrhea) | Not known |
Dyspnoea (dyspnea) | Not known |
Erythema | Not known |
Face oedema | Not known |
Hypersensitivity | Not known |
Hyperthyroidism | Not known |
Hypotension | Not known |
Injection site extravasation | Not known |
Injection site inflammation | Not known |
Injection site necrosis | Not known |
Injection site oedema | Not known |
Injection site pain | Not known |
Laryngeal oedema | Not known |
Laryngospasm | Not known |
Maculopapular rash | Not known |
Malaise | Not known |
Myocardial infarction | Not known |
Nausea | Not known |
Oedema | Not known |
Paraesthesia (paresthesia) | Not known |
Paralysis | Not known |
Paresis | Not known |
Pruritus | Not known |
Pulmonary oedema | Not known |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
Respiratory arrest | Not known |
Sensation of heat (Feeling of warmth) (Sensation of warmth) | Not known |
Shakiness | Not known |
Syncope | Not known |
Tachycardia | Not known |
Throat tightness | Not known |
Thrombophlebitis | Not known |
Thyroid disorder | Not known |
Thyrotoxic crisis (Thyroid crisis) | Not known |
Urticaria | Not known |
Vertigo | Not known |
Vomiting | Not known |
Telebrix 30 Meglumine° :
Different Units By MoH Code
Telebrix 30 Meglumine° MoH 121 :
Form | Solution for injection |
Packaging | Vial (Type II Glass) |
Package Size | 100ml |
Strength | 66.03g/100ml |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 26624 |
Submission date | 01/01/1989 |
Registration Year | 1989 |
Archived Date | 2019 |
Withdrawn Date | 08/04/2022 |
Price Comparison
● Country: | Belgium | |
● Package Size: | 1x100ml | |
● Public Price: | 17.64 EUR | ( 1,708,892.64 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 17,64 EUR | ( 1,646,892.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 18/06/2019 | |
● Type: | Medicine Withdrawn |
● Country: | Czech Republic | |
● Package Size: | 1x100ml | |
● Public Price: | 307.28 CZK | ( 1,173,502.32 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 307,28 CZK | ( 1,172,433.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 100ml | |
● Public Price: | 10 EUR | ( 968,760.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 10 EUR | ( 968,760.00 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/03/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Turkey | |
● Package Size: | 1 | |
● Public Price: | 46.07 TRY | ( 123,467.60 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 46,07 TRY | ( 123,280.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Portugal |
● Package Size: | 100ml |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
● Pricing Date: | 22/04/2019 |
You have to register to view this info
Drop File